James Roane v. Michele Leonhart

741 F.3d 147, 408 U.S. App. D.C. 206, 87 Fed. R. Serv. 3d 1101, 2014 WL 259659, 2014 U.S. App. LEXIS 1353
CourtCourt of Appeals for the D.C. Circuit
DecidedJanuary 24, 2014
Docket12-5020
StatusPublished
Cited by28 cases

This text of 741 F.3d 147 (James Roane v. Michele Leonhart) is published on Counsel Stack Legal Research, covering Court of Appeals for the D.C. Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
James Roane v. Michele Leonhart, 741 F.3d 147, 408 U.S. App. D.C. 206, 87 Fed. R. Serv. 3d 1101, 2014 WL 259659, 2014 U.S. App. LEXIS 1353 (D.C. Cir. 2014).

Opinion

Opinion for the Court filed by Circuit Judge GRIFFITH.

GRIFFITH, Circuit Judge:

Federal death row inmate Jeffrey Paul moved to intervene in this lawsuit, which challenges the government’s method of carrying out lethal injections and its failure to disclose its execution procedures. The district court denied his motion. For the reasons set forth below, we reverse.

I

Three federal death row inmates filed this lawsuit in December 2005 against vari *149 ous officials responsible for designing and implementing the federal lethal injection protocol. * Although their primary claim alleged that the three-drug cocktail called for in the protocol violated the Eighth Amendment’s bar against cruel and unusual punishment, the inmates also brought a due process challenge to the government’s refusal to disclose the procedures that would be used to execute them. The district court stayed their executions pending the resolution of these claims.

The inmates’ lawsuit has not proceeded quickly. The suit was stayed in February 2006 pending the outcome of Hill v. McDonough, 547 U.S. 573, 126 S.Ct. 2096, 165 L.Ed.2d 44 (2006), which raised the question of whether a challenge to a state lethal injection protocol could proceed under 42 U.S.C. § 1983. In June 2006, the Supreme Court announced that it could. In the wake of the decision in Hill, the government successfully sought extensions of time in August 2006 and October 2006 to answer the inmates’ complaint, finally doing so in November 2006. By the time of the original discovery deadline in June 2007, little discovery had been conducted and not a single deposition had been taken. That same month, the district court allowed three other death row inmates to intervene in the suit and ordered that discovery be extended until January 2008. But in December 2007, the suit was stayed once again pending the resolution of Baze v. Rees, 553 U.S. 35, 128 S.Ct. 1520, 170 L.Ed.2d 420 (2008), an Eighth Amendment challenge to Kentucky’s lethal-injection protocol. When the Supreme Court upheld Kentucky’s protocol, the litigation in this case resumed, though activity was limited to some additional discovery and motions.

In April 2011, the government notified the district court that sodium thiopental, one of the three drugs used to carry out executions as called for by the federal protocol, was no longer available. (The record does not explain the reason why.) In July 2011, the government informed the court that in light of the unavailability of sodium thiopental it had decided to alter the drug mixture used in its executions. Since then, activity in this case has been limited to the government filing monthly status reports as it continues the still-uncompleted process by which it will eventually determine what drug combination will be used. In the meantime, the inmates’ claims remain unresolved.

Paul, who had already been convicted of murder and sentenced to death, see United States v. Paul, 217 F.3d 989, 995 (8th Cir.2000), moved to intervene, both permissively and as of right, on October 6, 2009, the day after his unsuccessful post-conviction proceedings came to a close. Paul’s motion stipulated that he would not seek to revisit any of the issues already decided by the district court, the same concession made by three other death row inmates who the district court allowed to intervene in 2007.

Paul pointed to this concession and the fact that the litigation was still in its early *150 stages to argue that his intervention motion was timely because granting it would not disrupt or delay the current litigation to the detriment of the existing parties. But the district court denied his motion as untimely, characterizing Paul’s argument that the litigation would not be disrupted as “speculation” and emphasizing the significant amount of time that had elapsed since the suit was filed in 2005. Paul unsuccessfully moved for reconsideration by the district court. When his motion was denied, he appealed to this court. We have jurisdiction under 28 U.S.C. § 1291.

II

According to the government, we need not reach the merits of Paul’s appeal because it has been rendered moot by the unavailability of sodium thiopental. Even though it was not raised below, we consider the suggestion of mootness because it “implicates our jurisdiction.” St. Paul Fire & Marine Ins. Co. v. Barry, 438 U.S. 531, 537, 98 S.Ct. 2923, 57 L.Ed.2d 932 (1978).

The mootness doctrine is rooted in the constitutional requirement that “limits federal courts to deciding actual, ongoing controversies.” Am. Bar Ass’n v. FTC, 636 F.3d 641, 645 (D.C.Cir.2011) (internal quotation marks omitted). “A case becomes moot ... when the issues presented are no longer live or the parties lack a legally cognizable interest in the outcome.” Already, LLC v. Nike, Inc., — U.S. -, 133 S.Ct. 721, 726, 184 L.Ed.2d 553 (2013) (internal quotation marks omitted). Accordingly, even if “litigation poses a live controversy when filed,” a court is required to “refrain from deciding it if events have so transpired that the decision will neither presently affect the parties’ rights nor have a more-than-speculative chance of affecting them in the future.” Am. Bar Ass’n, 636 F.3d at 645 (internal quotation marks omitted).

The government argues this suit is moot because it has ceased using the three-drug mixture that the inmates challenge. But this argument falters under the “voluntary cessation” exception to mootness, which states that a lawsuit is not mooted by a defendant’s voluntary cessation of challenged activity unless that defendant “demonstrates] that there is no reasonable expectation that the wrong will be repeated.” Id. at 648 (internal quotation marks omitted). Here, the government cannot meet that heavy burden because it has merely suspended executions using the three-drug cocktail called for by the current protocol and has not yet issued a new protocol. The government further argues that the unavailability of sodium thiopental removes the very reason Paul seeks to join the lawsuit. Without sodium thiopental, no one can be executed using the three-drug cocktail Paul seeks to challenge. But the government’s argument overlooks the fact that not all of the claims in this lawsuit are tied to that cocktail. The inmates’ due process challenge, which attacks a refusal to disclose the procedures that will be used to execute them, is an independent claim that remains live regardless of whether the government can use the particular combination of drugs it has used in the past.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Amgen Inc. v. Xavier Becerra
District of Columbia, 2026
Liu v. Mayorkas
District of Columbia, 2022
Friends of the Earth v. Haaland
District of Columbia, 2021
Center for Biological Diversity v. Ross
District of Columbia, 2021
State of Connecticut v. Zinke
District of Columbia, 2018
Connecticut v. U.S. Dep't of the Interior
344 F. Supp. 3d 279 (D.C. Circuit, 2018)
In re: Herman Brewer
D.C. Circuit, 2017
Harrington v. Sessions
863 F.3d 861 (D.C. Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
741 F.3d 147, 408 U.S. App. D.C. 206, 87 Fed. R. Serv. 3d 1101, 2014 WL 259659, 2014 U.S. App. LEXIS 1353, Counsel Stack Legal Research, https://law.counselstack.com/opinion/james-roane-v-michele-leonhart-cadc-2014.